default author photo

Christoph Reinhard

Eli Lilly and Company, Ltd - Oncology Discovery Research

Indianapolis, IN

United States

  • Eli Lilly and Company, Ltd - Oncology Discovery Research

SCHOLARLY PAPERS

1

DOWNLOADS

70

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Genomic Characterization of Intrinsic and Acquired Resistance to Cetuximab in Colorectal Cancer Patients

Number of pages: 34 Posted: 04 Jan 2019
Steven M Bray, Jeeyun Lee, Seung Tae Kim, Sun Young Kim, Joon Young Hur, Philip J Ebert, John N Calley, Isabella H Wulur, Thejaswini Gopalappa, Swee Seong Wong, Hui-Rong Qian, Jason C Ting, Jiangang Liu, Melinda D Willard, Ruslan D Novosiadly, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Amit Aggarwal, Hee Cheol Kim and Christoph Reinhard
Eli Lilly and Company, Ltd, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - School of Medicine, Sungkyunkwan University, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - School of Medicine, Eli Lilly and Company, Ltd, Sungkyunkwan University - Department of Surgery and Eli Lilly and Company, Ltd - Oncology Discovery Research
Downloads 70 (875,328)

Abstract:

Loading...

Cetuximab, Acquired Resistance, Colorectal Cancer